(Q39747565)

14 September 2017

1 reference

title

In vitro and pharmacokinetic properties of the carbapenems (English)

1 reference

14 September 2017

carbapenem antibiotic

0 references

1 reference

1

Wise R

1 reference

PMC publication ID

180556

14 September 2017

language of work or name

English

0 references

publication date

1 September 1986

1 reference

Antimicrobial Agents and Chemotherapy

14 September 2017

1 reference

14 September 2017

30

1 reference

14 September 2017

3

1 reference

14 September 2017

343-349

1 reference

Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

MK0787 (N-formimidoyl thienamycin): evaluation of in vitro and in vivo activities

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Thienamycin: development of imipenen-cilastatin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

In vitro activity of thienamycin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Olivanic acids, a family of beta-lactam antibiotics with beta-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Multiple-dose pharmacokinetics of imipenem-cilastatin

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Disposition of radiolabeled imipenem and cilastatin in normal human volunteers

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

The beta-lactamases of gram-negative bacteria and their possible physiological role.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Antibacterial activity of imipenem: the first thienamycin antibiotic

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Imipenem-induced resistance to antipseudomonal beta-lactams in Pseudomonas aeruginosa

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Efficacy and safety of imipenem/cilastatin: a review of worldwide clinical experience.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

PS-6 and PS-7, new beta-lactam antibiotics. Isolation, physicochemical properties and structures.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

N-Acetimidoyl- and N-formimidoylthienamycin derivatives: antipseudomonal .beta.-lactam antibiotics

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

Pharmacokinetics and tolerance of N-formimidoyl thienamycin (MK0787) in humans

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180556

PS-5, a new beta-lactam antibiotic from Streptomyces

20 August 2018

1 reference

12 December 2020

Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383

1 reference

12 December 2020

Carpetimycins A and B, new beta-lactam antibiotics

1 reference

12 December 2020

N-formimidoyl-thienamycin a novel beta-lactam: an in-vitro comparison with other beta-lactam antibiotics

1 reference

12 December 2020

Asparenomycin A, a new carbapenem antibiotic

1 reference

12 December 2020

A novel beta-lactamase inhibitor, SF-2103 A produced by a Streptomyces

1 reference

12 December 2020

The structures of pluracidomycins, new carbapenem antibiotics

1 reference

12 December 2020

The carbapenem family

1 reference

12 December 2020

SQ 27,860, a simple carbapenem produced by species of Serratia and Erwinia

1 reference

12 December 2020

PS-8, a minor carbapenem antibiotic

1 reference

12 December 2020

Properties of MM 13902 and other carbapenem antibiotics in vitro and in vivo

1 reference

12 December 2020

Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila

1 reference

12 December 2020

Naturally-occurring beta-lactamase inhibitors with antibacterial activity

1 reference

12 December 2020

Olivanic acids, a family of .BETA.-lactam antibiotics with .BETA.-lactamase inhibitory properties produced by Streptomyces species. II. Isolation and characterisation of the olivanic acids MM 4550, MM 13902 and MM 17880 from Streptomyces olivaceus.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.32.295

Identifiers

DOI

10.1128/AAC.30.3.343

1 reference

14 September 2017

1 reference

PMC publication ID

180556

14 September 2017

PubMed publication ID

3535659

1 reference

PMC publication ID

180556